Association of occupational exposure with features of systemic sclerosis

Journal of the American Academy of Dermatology

Volumn 72, Issue 3, 2015, Pages 456-464

  Marie, Isabelle ^a,b   Menard, Jean François ^a   Duval Modeste, Anne Bénédicte ^a   Joly, Pascal ^a   Dominique, Stéphane ^a   Bravard, Pierre ^c   Noël, David ^d   Gehanno, Jean François ^a   Bubenheim, Michael ^a   Benichou, Jacques ^a   Levesque, Hervé ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c LE HAVRE HOSPITAL   (France)

^d Centre Hospitalier Général CHG Elbeuf   (France)

Author keywords

cancer; crystalline silica; digital ulcers; interstitial lung disease; occupational factors; solvents; systemic sclerosis

Indexed keywords

ORGANIC SOLVENT; SILICON DIOXIDE; SOLVENT;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FINGER ULCER; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL DYSFUNCTION; NEOPLASM; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; TASK PERFORMANCE; ADVERSE EFFECTS; CHEMICALLY INDUCED; DERMATITIS, OCCUPATIONAL; DIFFUSE SCLERODERMA; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

ADULT; AGED; DERMATITIS, OCCUPATIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROSPECTIVE STUDIES; SCLERODERMA, DIFFUSE; SCLERODERMA, SYSTEMIC; SILICON DIOXIDE; SOLVENTS;

EID: 84925451743     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.11.027     Document Type: Article

References (36)

1. I. Marie, S. Dominique, and H. Levesque Esophageal involvement and pulmonary manifestations in systemic sclerosis Arthritis Rheum 45 2001 346 354
2. I. Marie, J.F. Gehanno, and M. Bubenheim Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature Autoimmun Rev 13 2014 151 156
3. I. Marie, G. Gourcerol, A.M. Leroi, J.F. Ménard, H. Levesque, and P. Ducrotté Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis Arthritis Rheum 64 2012 2346 2355
4. R.K. Burt, M.C. Oliveira, and S.J. Shah Cardiac involvement and treatment-related mortality after non-myeloablative hemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis Lancet 381 2013 1116 1124
5. M. Elhai, C. Meune, J. Avouac, A. Kahan, and Y. Allanore Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-Analysis of cohort studies Rheumatology (Oxford) 51 2012 1017 1026
6. C. Ferri, G. Valentini, F. Cozzi Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients Medicine (Baltimore) 81 2002 139 153
7. N.S. Goh, S.R. Desai, and S. Veeraraghavan Interstitial lung disease in systemic sclerosis: a simple staging system Am J Respir Crit Care Med 177 2008 1248 1254
8. J. Magnant, M. de Monte, and J.L. Guilmot Relationship between occupational risk factors and severity markers of systemic sclerosis J Rheumatol 32 2005 1713 1718
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581 590
10. E.C. LeRoy, C. Black, and R. Fleischmajer Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 1988 202 205
11. J. Bourré-Tessier, C.A. Peschken, S. Bernatsky Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators, Pineau CA Association of smoking with cutaneous manifestations in systemic lupus erythematosus Arthritis Care Res (Hoboken) 65 2013 1275 1280
12. P. Chaudhary, X. Chen, and S. Assassi Cigarette smoking is not a risk factor for systemic sclerosis Arthritis Rheum 63 2011 3098 3102
13. F. van den Hoogen, D. Khanna, and J. Fransen 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative Arthritis Rheum 65 2013 2737 2747
14. I. Marie, M. Antonietti, and E. Houivet Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis Aliment Pharmacol Ther 40 2014 189 199
15. R.M. Lang, M. Bierig, R.B. Devereux Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. R. Mizuno, S. Fujimoto, Y. Saito, and S. Nakamura Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodeling in systemic sclerosis: 7-year follow-up study Eur J Heart Fail 12 2010 268 275
17. P.J. Nietert, S.E. Sutherland, R.M. Silver, J.P. Pandey, and M. Dosemeci Solvent oriented hobbies and the risk of systemic sclerosis J Rheumatol 26 1999 2369 2372
18. P.J. Nietert, S.E. Sutherland, and R.M. Silver Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41 1998 1111 1118
19. F.W. Miller, L. Alfredsson, and K.H. Costenbader Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop J Autoimmun 39 2012 259 271
20. D.H. Garabrant, and C. Dumas Epidemiology of organic solvents and connective tissue disease Arthritis Res 2 2000 5 15
21. N.J. McHugh, J. Whyte, G. Harvey, and U.F. Haustein Anti-topoisomerase I antibodies in silica-Associated systemic sclerosis: a model for autoimmunity Arthritis Rheum 37 1994 1198 1205
22. M.H. Rustin, H.A. Bull, and V. Ziegler Silica-Associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis Br J Dermatol 123 1990 725 734
23. V.D. Steen, C. Conte, G.R. Owens, and T.A. Medsger Jr. Severe restrictive lung disease in systemic sclerosis Arthritis Rheum 37 1994 1283 1289
24. P. Moinzadeh, N. Hunzelmann, and T. Krieg Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis J Am Acad Dermatol 65 2011 e102 e104
25. N. Sultan-Bichat, J. Menard, G. Perceau, F. Staerman, P. Bernard, and Z. Reguiaï Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy J Am Acad Dermatol 66 2012 424 429
26. V. Steen, C.P. Denton, J.E. Pope, and M. Matucci-Cerinic Digital ulcers: overt vascular disease in systemic sclerosis Rheumatology (Oxford) 48 Suppl 2009 iii19 iii24
27. T. Tingey, J. Shu, J. Smuczek, and J. Pope Meta-Analysis of healing and prevention of digital ulcers in systemic sclerosis Arthritis Care Res (Hoboken) 65 2013 1460 1471
28. M. Colaci, D. Giuggioli, and C. Vacchi Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian rheumatologic center and a population-based cancer registry and review of the literature Autoimmun Rev 13 2014 132 137
29. A.B. Olesen, C. Svaerke, D.K. Farkas, and H.T. Sorensen Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study Br J Dermatol 163 2010 800 806
30. A. Onishi, D. Sugiyama, S. Kumagai, and A. Morinobu Cancer incidence in systemic sclerosis: meta-Analysis of population-based cohort studies Arthritis Rheum 65 2013 1913 1921
31. E. Szekanecz, S. Szamosi, and A. Horvath Malignancies associated with systemic sclerosis Autoimmun Rev 11 2012 852 855
32. M. Bocchino, S. Agnese, and E. Fagone Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis PLoS One 5 2010 e14003
33. E.P. Martins, H.T. Fuzzi, and C. Kayser Increased chromosome damage in systemic sclerosis skin fibroblasts Scand J Rheumatol 39 2010 398 401
34. A.A. Shah, and A. Rosen Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications Curr Opin Rheumatol 23 2011 530 535
35. S.B. Wallach-Dayan, G. Izbicki, P.Y. Cohen, R. Gerstl-Golan, A. Fine, and R. Breuer Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway Am J Physiol Lung Cell Mol Physiol 290 2006 L790 L796
36. M. Wooten Systemic sclerosis and malignancy: a review of the literature South Med J 101 2008 59 62